AU2001276716A1 - Cyclic amine derivatives and use thereof - Google Patents

Cyclic amine derivatives and use thereof

Info

Publication number
AU2001276716A1
AU2001276716A1 AU2001276716A AU7671601A AU2001276716A1 AU 2001276716 A1 AU2001276716 A1 AU 2001276716A1 AU 2001276716 A AU2001276716 A AU 2001276716A AU 7671601 A AU7671601 A AU 7671601A AU 2001276716 A1 AU2001276716 A1 AU 2001276716A1
Authority
AU
Australia
Prior art keywords
cyclic amine
amine derivatives
derivatives
cyclic
amine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001276716A
Inventor
Goro Katsuura
Isako Sakaguchi
Toshisada Yano
Naoki Yoshikawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shionogi and Co Ltd
Original Assignee
Shionogi and Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi and Co Ltd filed Critical Shionogi and Co Ltd
Publication of AU2001276716A1 publication Critical patent/AU2001276716A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2001276716A 2000-08-08 2001-08-02 Cyclic amine derivatives and use thereof Abandoned AU2001276716A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000-239647 2000-08-08
JP2000239647 2000-08-08
PCT/JP2001/006673 WO2002012191A1 (en) 2000-08-08 2001-08-02 Cyclic amine derivatives and use thereof

Publications (1)

Publication Number Publication Date
AU2001276716A1 true AU2001276716A1 (en) 2002-02-18

Family

ID=18731147

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001276716A Abandoned AU2001276716A1 (en) 2000-08-08 2001-08-02 Cyclic amine derivatives and use thereof

Country Status (3)

Country Link
US (1) US6949656B2 (en)
AU (1) AU2001276716A1 (en)
WO (1) WO2002012191A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003068744A1 (en) * 2002-02-18 2003-08-21 Ishihara Sangyo Kaisha, Ltd. Pyridine derivatives or salts thereof and cytokine production inhibitors containing the same
KR20070001922A (en) 2003-12-12 2007-01-04 와이어쓰 Quinolines useful in treating cardiovascular disease
JP4904026B2 (en) * 2004-08-04 2012-03-28 日本曹達株式会社 Novel compound for forming photoreactive organic thin film and organic thin film forming body

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2960095D1 (en) 1978-04-12 1981-03-19 Ici Plc Blood platelet aggregation inhibitory tetrahydropyridine derivative, pharmaceutical compositions thereof and processes for its manufacture
EP0004727B1 (en) 1978-04-12 1981-08-12 Imperial Chemical Industries Plc Blood platelet aggregation inhibitory pyridine derivatives, pharmaceutical compositions thereof, and processes for their manufacture
GB2045750B (en) 1979-03-16 1982-12-15 Ici Ltd Process for the manufacture of 1-benzyl-1,2,3,6-tetrahydropyridine derivatives
FR2531707A1 (en) 1982-08-16 1984-02-17 Midy Spa SUBSTITUTED TRIFLUOROMETHYLPHENYLTETRAHYDROPYRIDINES WITH ANOREXIGENIC ACTIVITY, A PREPARATION PROCESS AND PHARMACEUTICAL COMPOSITIONS
US6433165B1 (en) * 1998-01-21 2002-08-13 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
CA2325472A1 (en) 1998-03-25 1999-09-30 Graham S. Poindexter Imidazolone anorectic agents: iii. heteroaryl derivatives
EP0978512A1 (en) * 1998-07-29 2000-02-09 Societe Civile Bioprojet Non-imidazole aryloxy (or arylthio) alkylamines as histamine H3-receptor antagonists and their therapeutic applications
KR20010103005A (en) * 1999-02-08 2001-11-17 시오노 요시히코 Cyclic amine derivatives and uses thereof

Also Published As

Publication number Publication date
US20040038966A1 (en) 2004-02-26
US6949656B2 (en) 2005-09-27
WO2002012191A1 (en) 2002-02-14

Similar Documents

Publication Publication Date Title
AU2001280187A1 (en) Cyclic amine derivatives
AU2001234175A1 (en) Novel cyclic amide derivatives
AU4796700A (en) Ureido-substituted cyclic amine derivatives and their use as drug
AU4145200A (en) Cyclic compounds and uses thereof
MXPA03006260A (en) Substituted amine derivatives and methods of use.
AU2001277754A1 (en) Proline derivatives and use thereof as drugs
AU2002235128A1 (en) Expression miniarrays and uses thereof
EP1367060A4 (en) Glucopyranosyloxybenzylbenzene derivatives and medicinal use thereof
EP1364957A4 (en) Glycopyranosyloxypyrazole derivatives and medicinal use thereof
EP1364958A4 (en) Glycopyranosyloxypyrazole derivatives and medicinal use thereof
HUP0300746A3 (en) Proline derivatives and use thereof as drugs
AU2002226487A1 (en) Novel c-glycoside derivatives and use thereof
AU8198901A (en) Novel heteroaryl derivatives and use thereof as medicaments
AU2001287898A1 (en) Pyrazolopyridines and pyrazolopyridazines as antidiabetics
AU2001267645A1 (en) Cyclic urea compounds and preparation thereof
AU2002308891A1 (en) Novel heterocyclic derivatives and medicinal use thereof
EP1392317A4 (en) Substituted 1-benzazepines and derivatives thereof
EP1207882A4 (en) Acyclic and cyclic amine derivatives
AU2001264273A1 (en) Amide compounds and use thereof
AU2001243601A1 (en) Caprolactam derivatives and uses thereof
HUP0401162A3 (en) Substituted c-furan-2-yl-methylamine and c-thiophen-2-yl-methylamine derivatives
AU2001276716A1 (en) Cyclic amine derivatives and use thereof
HUP0202377A2 (en) N-substituted perhydrodiazines, preparation and use thereof
AU7815201A (en) Synthetic salicylihalamides, apicularens and derivatives thereof
AU2320400A (en) Cyclic amine derivatives and uses thereof